Navigation Links
The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009'
Date:12/2/2009

LEXINGTON, Mass. and HEIDELBERG, Germany, Dec. 2 /PRNewswire/ -- febit's HybSelect has been recognized as one of the winners of the "Top 10 Innovations of 2009" by The Scientist magazine. The company's automated sequence capture technology for high-throughput sequencing was selected due to its exceptional combinations of invention, vision and utility.

The Scientist gathered a panel of expert judges to evaluate a broad range of life science technologies and determined the best innovations to hit the life sciences market in 2009. The winners' list includes a variety of products that capture both intracellular and extracellular processes. HybSelect is a robust and automated method for selecting and enriching high-value target regions from the genome that enables cost-effective massively parallel sequencing.

"Next-Generation-Sequencing (NGS) is an accurate and high-performance technology for diagnostics and has been limited by throughput, cost, data management and automation issues," said Peer Staehler, chief scientific officer of febit. "Instead of analyzing large-sequence stretches of a single genome, researchers using HybSelect are now able to focus on targeted re-sequencing of interesting regions from many different patients in parallel."

HybSelect combines the advantages of microarray-based enrichment with patent protected microfluidic biochip technology and runs on the dedicated, highly automated instrument, the Geniom® RT Analyzer. It allows to conduct large scale clinical studies to identify SNPs and mutations as new biomarkers to receive statistically relevant data.

To read the full article of The Scientist please visit http://www.the-scientist.com/2009/12/1/41/1/

About febit

febit develops, produces and markets flexible automated solutions for enabling biochip applications in Life Sciences. febit's product portfolio includes various instruments, optimized assays and bioanalytical services, complemented by bioinformatics software and consulting.

The key applications are HybSelect, febit's innovative DNA capture method for Next-Generation-Sequencing, and hands-off, amplification free microRNA profiling. Both are taking advantage of the advanced microfluidics of the patented Geniom Biochip to offer the highest degree of automation, flexibility and efficiency available.

For more information, please visit www.febit.com.


          Contact: febit group, Eva Sterzel, eva.sterzel@febit.de,
                              +49 (0)6221 6510-300
                     Russo Partners, Martina Schwarzkopf,
         martina.schwarzkopf@russopartnersllc.com, +1 212 845-4292

SOURCE febit


'/>"/>
SOURCE febit
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Two Hutchinson Center Scientists Receive a Total of $16.7 Million for Collaborative Stem Cell Research
2. Roche Scientist Recognized for Excellence in Peptide Chemistry
3. New Cardiovascular Biomarker Available for Scientist in North America
4. Scientists Identify Gene for Short Circuiting Excess Mucous in Lung Disease, Common Colds
5. IBM Scientists First to Image the Anatomy of a Molecule
6. Scientists Discover Origin of Malaria
7. International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit
8. Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy
9. Scientists Discover a Role for the Growth Factor TGF-beta in Maintaining Health of Retinal Blood Vessels
10. Scientists Discover Why Teeth Form in a Single Row
11. Scientists Unmask Genetic Markers Associated With Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
Breaking Medicine News(10 mins):